Monoclonal antibodies have transformed the treatment of rheumatoid arthritis in the last 25 years.
And today? Today marks the 25th anniversary of the first phase 1 trial of immunotherapy for rheumatoid arthritis [Isaacs JD, Hale G, Cobbold SP, Waldmann H, Watts RA, Hazleman BL, Keogan T 1992 Humanised monoclonal antibody therapy for rheumatoid arthritis Lancet Volume 340, No. 8822, p748–752, 26 September 1992].
While monoclonal antibodies treatments have transformed the treatment of RA the search for a cure continues. The story is not yet over and this week saw the launch of the RTCure project in Stockholm. You can follow this project on the Twitter handle @RTCure_eu https://twitter.com/RTCure_eu